DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Nihonbashi Life Science Building 10F 1006/1007 Meeting Room

2025年8月01日 (金) 午後 2:30 - 2025年8月01日 (金) 午後 5:00

2-3-11 Nihonbashihoncho, Chuo-ku, Nihonbashi Life Science Building 10F, Tokyo, 103-0023 Japan

5th DIA COMMUNITY DAY

概要

5th Community Day will be conducted in Japanese Language only.

Click Here to View the Flyer in Japanese

 Registration has been closed as the number of participants has exceeded the venue's capacity.

Thank you for your understanding.

プログラム委員会

  • Kotone  Matsuyama, RPh
    Kotone Matsuyama, RPh Center for Clinical Research and Development
    National Center for Child Health and Development, Japan
  • Noriaki  Nagao, MPharm, PMP
    Noriaki Nagao, MPharm, PMP Pharmaceutical Division,Clinical Development Dept.
    JAPAN TOBACCO INC., Japan
  • Keiko  Tsumori, MSc
    Keiko Tsumori, MSc Associate Principle Scientist, Medical Writing, Regulatory Affairs Area, Japan D
    MSD K.K., Japan
  • Naoki  Isogawa, PhD
    Naoki Isogawa, PhD Biometrics & Quantitative Sciences East Asia (BQS), Head of BQS East Asia
    UCB Japan Co., Ltd., Japan
  • Yuu  Jincho, JD, MSc
    Yuu Jincho, JD, MSc Manager, Data Practice Group, Biomedical Data Sciences Dept., RD Japan
    GlaxoSmithKline K.K., Japan
  • Masaaki  Jitsu
    Masaaki Jitsu
    Bayer Yakuhin Ltd, Japan
  • Keiko  Katsui, PhD
    Keiko Katsui, PhD Division of Biomedical Ethics and Social Co-Creation
    Japan Agency for Medical Research and Development (AMED), Japan
  • Kentaro  Kogushi, PhD
    Kentaro Kogushi, PhD Head of Clinical Development Neurology-Psychiatry, Japan Development
    AbbVie GK, Japan
  • Mika  Maeda
    Mika Maeda Lecturer, Section for Human Research Protections, Kitasato University Hospital
    School of Pharmacy, Kitasato University, Japan
  • Kana  Maruyama
    Kana Maruyama Manager, Regulatory Labeling, Regulatory Affairs
    Viatris Pharmaceuticals Japan GK, Japan
  • So  Miyoshi
    So Miyoshi Head of Clinical Pharmacology & Bioanalytics
    Pfizer R&D Japan, Japan
  • Makoto  Nagaoka, PhD
    Makoto Nagaoka, PhD Senior Director, Global Regulatory Affairs Strategy, Consulting
    Fortrea Japan K.K., Japan
  • Tomoharu  Numanyu
    Tomoharu Numanyu Reviewe, Safety II
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Hiromi  Okabe, PhD
    Hiromi Okabe, PhD Oncology & Rare Disease, Regulatory Strategy, Regulatory Affairs
    Amgen K.K., Japan
  • Goshi  Ozawa, MS
    Goshi Ozawa, MS CEO
    Real Discovery Outdorrs K.K., Japan
  • Marie  Shiga
    Marie Shiga
    Pfizer Japan Inc., Japan
  • Keisuke  Suzuki, PhD
    Keisuke Suzuki, PhD Director, Innovation Center for Translational Research
    National Center for Geriatrics and Gerontology, Japan
  • Tadashi  Urashima, PhD
    Tadashi Urashima, PhD Performance and Digital Analytics Lead, Japan Development
    GlaxoSmithKline K.K., Japan
  • Miyoko  Yamauchi
    Miyoko Yamauchi Head, Human Capital Development Group
    CHUGAI PHARMACEUTICAL CO., LTD., Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。